Your browser doesn't support javascript.
Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation.
Gao, Ting; Zhu, Lin; Liu, Hainan; Zhang, Xiaopeng; Wang, Tingting; Fu, Yangbo; Li, Hongzhen; Dong, Qincai; Hu, Yong; Zhang, Zhang; Jin, Jing; Liu, Zijing; Yang, Weihong; Liu, Yaoning; Jin, Yanwen; Li, Kaitong; Xiao, Yongjiu; Liu, Junli; Zhao, Huailong; Liu, Yue; Li, Ping; Song, Jibo; Zhang, Lu; Gao, Yuwei; Kang, Sisi; Chen, Shoudeng; Ma, Qingjun; Bian, Xiuwu; Chen, Wei; Liu, Xuan; Mao, Qing; Cao, Cheng.
  • Gao T; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Zhu L; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Liu H; Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, 230601, China.
  • Zhang X; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Wang T; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Fu Y; Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, 230601, China.
  • Li H; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Dong Q; Beijing Key Laboratory of Bio-products Safety Assessment, Joinn Laboratories (China) Co. Ltd, Beijing, 100176, China.
  • Hu Y; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Zhang Z; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Jin J; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Liu Z; Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, 230601, China.
  • Yang W; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Liu Y; Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, 230601, China.
  • Jin Y; Institute of Physical Science and Information Technology, Anhui University, Hefei, Anhui, 230601, China.
  • Li K; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Xiao Y; Beijing Key Laboratory of Bio-products Safety Assessment, Joinn Laboratories (China) Co. Ltd, Beijing, 100176, China.
  • Liu J; The 940th Hospital of the People's Liberation Army, Lanzhou, Gansu, 730050, China.
  • Zhao H; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Liu Y; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Li P; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Song J; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Zhang L; Department of Gastroenterology, the 960th Hospital of the People's Liberation Army, Zibo, Shandong, 255300, China.
  • Gao Y; The 940th Hospital of the People's Liberation Army, Lanzhou, Gansu, 730050, China.
  • Kang S; Academy of Military Medical Science of PLA, 666 Liuyingxi St, Changchun, 130122, China.
  • Chen S; Molecular Imaging Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Ma Q; Molecular Imaging Center, Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Bian X; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Chen W; First Affiliated Hospital, Army Medical University, Chongqing, 400038, China.
  • Liu X; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China.
  • Mao Q; Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, 100850, China. liux931932@163.com.
  • Cao C; First Affiliated Hospital, Army Medical University, Chongqing, 400038, China. qingmao@tmmu.edu.cn.
Signal Transduct Target Ther ; 7(1): 318, 2022 09 14.
Article in English | MEDLINE | ID: covidwho-2028663
ABSTRACT
Excessive inflammatory responses contribute to the pathogenesis and lethality of highly pathogenic human coronaviruses, but the underlying mechanism remains unclear. In this study, the N proteins of highly pathogenic human coronaviruses, including severe acute respiratory syndrome coronavirus (SARS-CoV), middle east respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were found to bind MASP-2, a key serine protease in the lectin pathway of complement activation, resulting in excessive complement activation by potentiating MBL-dependent MASP-2 activation, and the deposition of MASP-2, C4b, activated C3 and C5b-9. Aggravated inflammatory lung injury was observed in mice infected with adenovirus expressing the N protein. Complement hyperactivation was also observed in SARS-CoV-2-infected patients. Either blocking the N proteinMASP-2 interaction, MASP-2 depletion or suppressing complement activation can significantly alleviate N protein-induced complement hyperactivation and lung injury in vitro and in vivo. Altogether, these data suggested that complement suppression may represent a novel therapeutic approach for pneumonia induced by these highly pathogenic coronaviruses.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Injury / COVID-19 Limits: Animals / Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01133-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Injury / COVID-19 Limits: Animals / Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01133-5